Sign in

CIK 0001820190 · <br>Emerging growth company

Scilex Holding Co

Sign in to watch
Ticker
SCLX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(650) 516-4310
Business address
960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
Former names
Scilex Holding Company/DE, Vickers Vantage Corp. I

Securities

  • SCLX Common Stock Nasdaq
  • SCLXW Warrant Nasdaq
  1. 4 Other disposition 10% owner disposed of 5,000,000 shares (other)
  2. 4 Open-market buy See Remarks bought 30,000 shares at $0.46 ($13,800)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Executive Chairperson bought 8,888 shares at $0.94 ($8,351)
  7. 4 Open-market buy See Remarks bought 32,000 shares at $0.99 ($31,670)
  8. 4 Open-market buy Director bought 1,000 shares at $0.99 ($990)
  9. 4 Open-market buy Director bought 5,000 shares at $0.95 ($4,750)
  10. 4 Open-market buy Director bought 20,000 shares at $0.95 ($18,992)
  11. 4 Open-market buy Director bought 2,000 shares at $0.90 ($1,800)
  12. 4 Open-market buy Executive Chairperson bought 10,000 shares at $0.97 ($9,710)
  13. 4 Open-market buy See Remarks bought 30,000 shares at $0.99 ($29,751)
  14. 4 Open-market buy Chief Financial Officer bought 6,700 shares at $0.97 ($6,499)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Option exercise Director acquired 1,000 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Option exercise Director acquired 5,000 shares (option exercise)

Page 2 of 5 · 93 filings